Morgan D. Elwyn

Partner

New York
Willkie Farr & Gallagher LLP
787 Seventh Avenue
New York, NY 10019-6099
T 212 728 8981
F 212 728 9981
melwynwillkie.com

Morgan Elwyn is a partner in the Corporate and Financial Services Department. Morgan’s practice includes mergers and acquisitions, joint ventures, private equity transactions and capital market transactions. In the private equity area, Morgan’s practice include early stage and growth equity investments, mergers and acquisitions as well as portfolio company representation.

Highlights

Morgan Elwyn is a partner in the Corporate and Financial Services Department. Morgan’s practice includes mergers and acquisitions, joint ventures, private equity transactions and capital market transactions. In the private equity area, Morgan’s practice include early stage and growth equity investments, mergers and acquisitions as well as portfolio company representation.

Selected Significant Matters

Morgan’s experience includes the following representations:

  • Insight Venture Partners and WorkForce Software in WorkForce’s acquisition of Workplace
  • LOGICnow in its acquisition by SolarWinds
  • Warburg Pincus and the Association of Certified Anti-Money Laundering Specialists (ACAMS) in the $330 million sale of ACAMS to Becker Professional Education
  • Conga in its acquisitions of Novatus, ActionGrid and CRMCulture
  • Insight Venture Partners in its acquisition of Diligent, a take-private transaction valued at approximately $624 million
  • MedAssets in its acquisition by Pamplona Capital Management for $2.7 billion
  • Syncsort in its acquisition by Clearlake Capital Group
  • Valtech Cardio in its proposed acquisition by HeartWare International for $875 million
  • Insight Venture Partners in its investment in Thycotic
  • Appriss in its acquisition of The Retail Equation
  • Insight Venture Partners in its acquisition of Fourth
  • Insight Venture Partners in its $70 million investment in Conga
  • HealthcareSource in its acquisition by Francisco Partners
  • Insight Venture Partners in the acquisition of E2open
  • AdColony in its acquisition by Opera
  • MedAssets, Inc. in its acquisition of Sg-2, LLC.
  • GFI Software in the sale of TeamViewer to Permira
  • Insight Venture Partners in its leveraged acquisition of WorkForce Software
  • Insight Venture Partners and its portfolio company ECi Software Solutions in the sale of ECi to The Carlyle Group
  • Insight Venture Partners in its significant investment in Kaseya
  • Insight Venture Partners in the $6.9 billion consortium acquisition of BMC Software
  • Insight Venture Partners in the $2 billion buyout agreement to take Quest Software private
  • Insight Venture Partners as lead investor in the $165 million equity financing of Drilling Info, Inc., acquiring majority ownership of the company
  • Teva Pharmaceutical Industries Limited in its consumer health care joint venture with The Procter & Gamble Company
  • MedAssets, Inc. in connection with its acquisition of The Broadlane Group
  • MedAssets, Inc. in connection with its acquisition of Accuro Healthcare Solutions, Inc.
  • Insight Venture Partners and Lightyear Capital Partners in the acquisition of Realm Business Solutions and subsequent disposition to Altus Group Limited
  • Cablevision Special Committee in connection with the spin-off of the Madison Square Garden business and regarding proposed going private transactions with the Dolan family
  • MedAssets, Inc. in connection with its initial public offering of common stock
  • Eagle Family Foods, Inc. in connection with its sale to The J.M. Smucker Company
  • Fortent, Inc. in connection with its sale to NICE Systems Ltd.
  • Scriptlogic, Inc. in connection with its sale to Quest Software
  • ColBar Lifescience Ltd. in connection with its sale to Johnson & Johnson
  • GateHouse Media, Inc. in connection with its initial public offering of common stock
  • GateHouse Media, Inc. in connection with its acquisitions of Community Newspaper Company and Enterprise News Media
  • Insight Venture Partners in its acquisition of eCommerce Industries, Inc.
  • Teva Pharmaceutical Industries Limited in a $2.9 billion offering of senior notes